Hugel showcases global K-aesthetics momentum at AMWC KOREA Share Post Post navigation Previous PostInnovent Biologics Announces First Patient Dosed in a Phase 3 Clinical Trial of IBI3003(GPRC5D/BCMA/CD3 Tri-specific Antibody) for the Treatment of Multiple MyelomaNext Post Circles, Greyskies, and HCLTech Collaborate in TM Forum Catalyst Program to Accelerate AI-led Autonomous Network Operations